SCHEMBL411877

SCHEMBL411877

S=NS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4488154 0.61
SCHEMBL14562972 0.55
SCHEMBL4138939 0.50
SCHEMBL2938390 0.47
SCHEMBL35638 0.47
SCHEMBL23453889 0.41
SCHEMBL6282335 0.41
SCHEMBL11667248 0.41
SCHEMBL156040 0.41
SCHEMBL1316766 0.41

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118384062-A Gas-producing functional molecule modified liposome, preparation method and application thereof, and cosmetic preparation 美归(成都)生物材料合伙企业(有限合伙) 2024-07-26 CN disclosed
US-20170356004-A1 MULTIPLE VIRUS RESISTANCE IN PLANTS MONSANTO TECHNOLOGY LLC (US) 2017-12-14 US disclosed
CN-104254533-B The pyridinyl compounds of thiazole or thiadiazoles substitution as kinase inhibitor 百时美施贵宝公司 2017-09-08 CN disclosed
US-9683269-B2 Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof HVIDOVRE HOSPITAL (DK) 2017-06-20 US disclosed
CN-104169275-B The pyridine compounds of the triazole substitution as kinase inhibitor 百时美施贵宝公司 2017-06-09 CN disclosed
CN-104159896-B Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors 百时美施贵宝公司 2017-05-24 CN disclosed
US-9598456-B2 Modified cytosine polynucleotide oligomers and methods CEPHEID (US) 2017-03-21 US disclosed
US-9598455-B2 Modified thymine polynucleotide oligomers and methods CEPHEID (US) 2017-03-21 US disclosed
US-20170066724-A1 ANALOGS OF FEXARAMINE AND METHODS OF MAKING AND USING SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2017-03-09 US disclosed
US-9260572-B2 CNT-polymer complex capable of self-doping by external stimuli and process for preparing the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2016-02-16 US disclosed
US-8506969-B2 Efficient cell culture system for hepatitis C virus genotype 7a HVIDOVRE HOSPITAL (DK) 2013-08-13 US disclosed
US-20120061628-A1 COPPER TIN SULFIDE AND COPPER ZINC TIN SULFIDE INK COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-03-15 US disclosed
US-20110294195-A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a HVIDOVRE HOSPITAL (DK) 2011-12-01 US disclosed
US-20110059513-A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 1A AND 1B HVIDOVRE HOSPITAL (DK) 2011-03-10 US disclosed
US-20110059512-A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 6A HVIDOVRE HOSPITAL (DK) 2011-03-10 US disclosed
US-20100093841-A1 CELL CULTURE SYSTEM OF A HEPATITIS C GENOTYPE 3A AND 2A CHIMERA HVIDOVRE HOSPITAL (DK) 2010-04-15 US disclosed
US-7504900-B2 Integrated circuit package including programmable oscillators SILICON LABS CP, INC. (US) 2009-03-17 US disclosed
US-7498962-B2 Analog-to-digital converter with low power track-and-hold mode SILICON LABS CP, INC. (US) 2009-03-03 US disclosed
US-20070103357-A1 ANALOG-TO-DIGITAL CONVERTER WITH LOW POWER TRACK-AND-HOLD MODE SILICON LABS CP, INC. (US) 2007-05-10 US disclosed
US-7171542-B1 Reconfigurable interface for coupling functional input/output blocks to limited number of i/o pins SILICON LABS CP, INC. (US) 2007-01-30 US disclosed